Nemes Rush Group LLC Abbott Laboratories Transaction History
Nemes Rush Group LLC
- $728 Billion
- Q2 2024
A detailed history of Nemes Rush Group LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Nemes Rush Group LLC holds 2,676 shares of ABT stock, worth $314,831. This represents 0.04% of its overall portfolio holdings.
Number of Shares
2,676
Previous 2,672
0.15%
Holding current value
$314,831
Previous $304 Million
8.44%
% of portfolio
0.04%
Previous 0.04%
Shares
5 transactions
Others Institutions Holding ABT
# of Institutions
3,173Shares Held
1.33BCall Options Held
8.62MPut Options Held
7.18M-
Vanguard Group Inc Valley Forge, PA166MShares$19.6 Billion0.34% of portfolio
-
Black Rock Inc. New York, NY131MShares$15.4 Billion0.31% of portfolio
-
State Street Corp Boston, MA74.4MShares$8.75 Billion0.34% of portfolio
-
Capital International Investors Los Angeles, CA71.8MShares$8.45 Billion1.57% of portfolio
-
Capital Research Global Investors Los Angeles, CA57.2MShares$6.73 Billion1.34% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $206B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...